Financhill
Sell
49

CKPT Quote, Financials, Valuation and Earnings

Last price:
$3.14
Seasonality move :
-13.84%
Day range:
$3.07 - $3.21
52-week range:
$1.38 - $4.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
831.1K
Avg. volume:
1.9M
1-year change:
65.45%
Market cap:
$154.3M
Revenue:
$103K
EPS (TTM):
-$1.84

Earnings Data

Next earnings date for CKPT
Mar 21
2025
Most recent earnings per share
-$0.23
Missed by $0.23
(Nov 12/2024)
Consensus Estimate
--
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CKPT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $4.5M -- -- -- --
03/21/2025 Q4 $10.3K -- -- -- --
11/12/2024 Q3 $10.3K -- -$0.23 -- --
08/12/2024 Q2 $10.3K $41K -$0.18 -- --
05/10/2024 Q1 $10K -- -$0.33 -- --
03/22/2024 Q4 $22.5K $6K -$1.10 -- --
11/13/2023 Q3 -- -- -$0.29 -- --
08/14/2023 Q2 -- -- -$1.05 -- --
05/15/2023 Q1 -- -- -$0.89 -- --
03/30/2023 Q4 -- -- -$2.31 -- --
11/08/2022 Q3 -- -- -$1.20 -- --
08/12/2022 Q2 -- -- -$1.62 -- --
05/12/2022 Q1 -- -- -$1.98 -- --
03/28/2022 Q4 -- -- -$3.85 -- --
11/04/2021 Q3 -- -- -$1.40 -- --
08/05/2021 Q2 -- -- -$1.20 -- --
05/07/2021 Q1 -- -- -$0.90 -- --
03/09/2021 Q4 -- -- -$1.70 -- --
11/04/2020 Q3 -- -- -$0.90 -- --
08/06/2020 Q2 -- -- -$0.90 -- --
05/06/2020 Q1 -- -- -$0.60 -- --
03/11/2020 Q4 -- -- -$2.20 -- --
11/12/2019 Q3 -- -- -$1.50 -- --
08/08/2019 Q2 -- -- -$1.50 -- --
05/10/2019 Q1 -- -- -$1.80 -- --
03/15/2019 Q4 -- -- -$3.80 -- --
11/02/2018 Q3 -- -- -$3.20 -- --
06/30/2018 Q2 -- -- -$2.30 -- --
03/31/2018 Q1 -- -- -$3.50 -- --
03/15/2018 Q4 -- -- -$2.60 -- --
09/30/2017 Q3 -- -- -$2.60 -- --
06/30/2017 Q2 -- -- -$2.80 -- --
03/31/2017 Q1 -- -- -$2.00 -- --
12/31/2016 Q4 -- -- -$3.41 -- --
09/30/2016 Q3 -- -- -$2.10 -- --
06/30/2016 Q2 -- -- -$2.21 -- --
03/31/2016 Q1 -- -- -$1.48 -- --
12/31/2015 Q4 -- -- -$3.30 -- --
09/30/2015 Q3 -- -- -$1.53 -- --

Checkpoint Therapeutics Earnings Questions

  • How Much did Checkpoint Therapeutics Generate in Revenue Last Quarter?

    Checkpoint Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Checkpoint Therapeutics Beat Earnings Last Quarter?

    Checkpoint Therapeutics announced earnings per share of -$0.23 which represents a miss of analyst forecast a -- per share.

  • Is Checkpoint Therapeutics Profitable?

    Checkpoint Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Checkpoint Therapeutics EPS Next Year?

    Checkpoint Therapeutics's earnings are forecast to grow from -$3.17 per share to -- per share next year representing an increase of --.

  • When is Checkpoint Therapeutics's Earnings Date?

    Checkpoint Therapeutics's next earnings date is March 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock